21
David W Robertson: Endoscope with distal tip having encased optical components and display orientation capabilities. Boston Scientific Scimed, Bookoff McAndrews PLLC, December 10, 2013: US08602967 (7 worldwide citation)

An apparatus according to one embodiment includes an endoscope tip including a housing that is monolithically formed of a transparent material. At least one optical component is at least partially encased within the housing. The optical component can be, for example, a light source, a fiber optic, a ...


22
David W Robertson: Endoscope with distal tip having encased optical components and display orientation capabilities. Boston Scientific Scimed, Bookoff McAndrews PLLC, July 16, 2013: US08485966 (7 worldwide citation)

An apparatus according to one embodiment includes an endoscope tip including a housing that is monolithically formed of a transparent material. At least one optical component is at least partially encased within the housing. The optical component can be, for example, a light source, a fiber optic, a ...


23
David W Robertson, David T Wong: 3-phenyloxy-3-phenyl propanamines. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, Nancy J Harrison, August 24, 1993: US05238959 (7 worldwide citation)

The present invention provides 3-(4-substitutedphenoxy)-3-phenyl propanamines capable of inhibiting the uptake of serotonin. These compounds are useful for treating many pharmacological disorders, including depression and obesity. These compounds can also be used to reduce the desire to smoke and co ...


24
Marlene L Cohen, David W Robertson: N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, August 25, 1992: US05141944 (7 worldwide citation)

This invention provides N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating sexual dysfunction, hypertension, migraine, vasosp ...


25
David W Robertson, David T Wong: 3,4-diphenylbutanamines. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, February 26, 1991: US04996235 (6 worldwide citation)

The present invention provides 3,4-diphenylbutanamines capable of selectively inhibiting the uptake of serotonin and norepinephrine.


26
Marlene L Cohen, William B Lacefield, David W Robertson: Specific 5-HT.sub.3 antagonists. Eli Lilly and Company, Robert A Conrad, November 15, 1994: US05364863 (6 worldwide citation)

This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.


27
David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, December 16, 1986: US04629740 (5 worldwide citation)

This invention provides for certain benzamide derivatives and their pharmaceutical formulations and their use as anticonvulsant agents.


28
Marlene L Cohen, David W Robertson: Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted) ergolines. Eli Lilly and Company, Joseph A Jones, Douglas J Taylor, August 15, 1995: US05441961 (4 worldwide citation)

The present invention provides (8.beta.)-N-substituted cyclo or bicycloalkyl-6-(substituted)-ergoline-8-carboxamides useful for occupying 5HT.sub.2 or 5HT.sub.1c receptors in mammals. The invention also provides methods for treating a variety of disorders and conditions related to or affecting these ...


29
Richard W Anderson, Sylvia S McBrinn, David W Robertson, Robert C Marshall: Compounds for the treatment of addictive disorders. Pharmacia & Upjohn, Pharmacia & Upjohn Company, Thomas A Wootton, January 11, 2005: US06841557 (4 worldwide citation)

The treatment of addictive disorders, psychoactive substance use disorders, intoxication disorders, inhalation disorders, alcohol addiction, tobacco addiction, and nicotine addiction using a heterocyclic amine, a phenylazacycloalkane, a cabergoline, or an aromatic bicyclic amine active agent, or a p ...


30
David W Robertson: 6-(pyridinylphenyl)dihydropyridazinones as inotropic agents. Eli Lilly and Company, Robert A Conrad, December 23, 1986: US04631279 (4 worldwide citation)

This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.



Click the thumbnails below to visualize the patent trend.